TOBRAMYCIN SULFATE
AMINOGLYCOSIDES, PARENTERAL · E. COLI SEPTICEMIA ·+44
FRESENIUS KABI
Drug class
Capreomycin and Parenteral Aminoglycosides
"Capreomycin and Parenteral Aminoglycosides" is an administrative and clinical grouping rather than a distinct, singular pharmacological class. Read more about Capreomycin and Parenteral Aminoglycosides
31 drugs in this class 23 manufacturers
Drugs in Capreomycin and Parenteral Aminoglycosides
GENTAMICIN SULFATE
AMINOGLYCOSIDES, PARENTERAL · SEPSIS CAUSED BY ENTEROBACTER ·+63
FRESENIUS KABI
TOBRAMYCIN SULFATE
AMINOGLYCOSIDES, PARENTERAL · E. COLI SEPTICEMIA ·+44
CLARIS/BAXTER
AMIKACIN SULFATE
AMINOGLYCOSIDES, PARENTERAL · STAPHYLOCOCCAL SEPTICEMIA ·+60
MULLAN PHARMACE
Filter & compare in the drug finder →
Opens the drug finder with Capreomycin and Parenteral Aminoglycosides preselected. Add indication or manufacturer filters there.
"Capreomycin and Parenteral Aminoglycosides" is an administrative and clinical grouping rather than a distinct, singular pharmacological class.
It encompasses parenterally administered second-line antituberculosis agents consisting of the cyclic peptide capreomycin alongside injectable aminoglycosides such as amikacin, kanamycin, and streptomycin.
These bactericidal or bacteriostatic agents work by binding to bacterial ribosomal subunits to disrupt protein synthesis and induce mistranslation.
Historically essential for multidrug-resistant tuberculosis and select severe mycobacterial infections, their clinical utility has significantly diminished in modern guidelines due to severe nephrotoxicity, ototoxicity, and the advent of safer, all-oral antituberculosis regimens.
-
nih.gov
"Capreomycin and Parenteral Aminoglycosides" is an administrative and clinical grouping rather than a distinct, singular pharmacological class It encompasses parenterally administered second-line antituberculosis agents consisting of the cyclic peptide capreomycin alongside injectable aminoglycosides such as amikacin, kanamycin, and streptomycin Historically essential for multidrug-resistant tuberculosis and select severe mycobacterial infections, their clinical utility has significantly diminis...
-
who.int
"Capreomycin and Parenteral Aminoglycosides" is an administrative and clinical grouping rather than a distinct, singular pharmacological class It encompasses parenterally administered second-line antituberculosis agents consisting of the cyclic peptide capreomycin alongside injectable aminoglycosides such as amikacin, kanamycin, and streptomycin
-
nih.gov
It encompasses parenterally administered second-line antituberculosis agents consisting of the cyclic peptide capreomycin alongside injectable aminoglycosides such as amikacin, kanamycin, and streptomycin These bactericidal or bacteriostatic agents work by binding to bacterial ribosomal subunits to disrupt protein synthesis and induce mistranslation
-
asm.org
These bactericidal or bacteriostatic agents work by binding to bacterial ribosomal subunits to disrupt protein synthesis and induce mistranslation
-
nih.gov
Historically essential for multidrug-resistant tuberculosis and select severe mycobacterial infections, their clinical utility has significantly diminished in modern guidelines due to severe nephrotoxicity, ototoxicity, and the advent of safer, all-oral antituberculosis regimens
-
who.int
Historically essential for multidrug-resistant tuberculosis and select severe mycobacterial infections, their clinical utility has significantly diminished in modern guidelines due to severe nephrotoxicity, ototoxicity, and the advent of safer, all-oral antituberculosis regimens
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.